SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-052069
Filing Date
2023-04-28
Accepted
2023-04-28 07:30:11
Documents
9
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2312680-2_def14a.htm DEF 14A 1214193
2 GRAPHIC lg_carismatherapeutics-4c.jpg GRAPHIC 101495
3 GRAPHIC sg_skwet-bw.jpg GRAPHIC 28491
4 GRAPHIC sg_sanfordzweifach-bw.jpg GRAPHIC 23285
5 GRAPHIC lg_mackenziepartners-bw.jpg GRAPHIC 31267
6 GRAPHIC bc_tsr-4c.jpg GRAPHIC 122925
7 GRAPHIC bc_netincome-4c.jpg GRAPHIC 111648
8 GRAPHIC px_page01-4c.jpg GRAPHIC 1076045
9 GRAPHIC px_page02-4c.jpg GRAPHIC 732894
  Complete submission text file 0001104659-23-052069.txt   4013719
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36296 | Film No.: 23860179
SIC: 2834 Pharmaceutical Preparations